Neurosurgery Supplies
News
-
Axogen to Participate at Upcoming Investor Conferences
Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical solutions for peripheral nerve injuries, today announced it will participate in two investor conferences in February. Karen Zaderej, chairman, CEO, and ...
Axogen, Inc. to Report Fourth Quarter and Full-Year 2021 Financial Results and Host Conference Call on February 22, 2022
Axogen to Participate at AAHS ASPN ASRM 2022 Annual Meetings
Axogen sponsors 2022 Donate Life Rose ParadeĀ® Float to help raise awareness of organ and tissue donation
Axogen, Inc. to Participate at Canaccord Genuity Virtual MedTech, Diagnostics and Digital Health & Services Forum
Equipment & Solutions
-
Showcase
Avance Nerve Graft
Avance Nerve Graft is an off-the-shelf processed human nerve allograft intended for the surgical repair of peripheral nerve discontinuities. Through a proprietary cleansing process for recovered human peripheral nerve tissue, the graft preserves the essential inherent structure of the ECM while cleansing away cellular and noncellular debris.